Selected article for: "monoclonal antibody and virus entry"

Author: Hualong Xiong; Yangtao Wu; Jiali Cao; Ren Yang; Jian Ma; Xiaoyang Qiao; Xiangyang Yao; Baohui Zhang; Yali Zhang; Wangheng Hou; Yang Shi; Jingjing Xu; Liang Zhang; Shaojuan Wang; Baorong Fu; Ting Yang; Shengxiang Ge; Jun Zhang; Quan Yuan; Baoying Huang; Zhiyong Li; Tianying Zhang; Ningshao Xia
Title: Robust neutralization assay based on SARS-CoV-2 S-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressed BHK21 cells
  • Document date: 2020_4_9
  • ID: fvjh3g7v_20
    Snippet: We firstly tested the response of VSVdG-SARS-CoV-2- [16] . It also means this pseudoviruse system can mimic the entry of live virus. This system can be used for high-throughput screening of neutralizing antibodies. As The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.08.026948 doi: bioRxiv preprint shown in Figure 5A and 5B, 35 strains of mouse monoclonal antibody hybridoma culture super.....
    Document: We firstly tested the response of VSVdG-SARS-CoV-2- [16] . It also means this pseudoviruse system can mimic the entry of live virus. This system can be used for high-throughput screening of neutralizing antibodies. As The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.08.026948 doi: bioRxiv preprint shown in Figure 5A and 5B, 35 strains of mouse monoclonal antibody hybridoma culture supernatants were evaluated using the pseudovirus system, and 7 of them showed significant neutralization. The IC50 of 7 selected neutralizing antibodies for antiviral activity were also analyzed ( Figure 5C ) using this pseudovirus system.

    Search related documents:
    Co phrase search for related documents
    • antiviral activity and high throughput: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral activity and high throughput screening: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral activity and live virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • antiviral activity and live virus entry: 1
    • culture supernatant and high throughput: 1, 2, 3
    • culture supernatant and live virus: 1
    • high throughput and live virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • high throughput and live virus entry: 1, 2
    • high throughput and pseudovirus system: 1, 2, 3
    • high throughput screening and live virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • high throughput screening and live virus entry: 1, 2
    • live virus and neutralize antibody: 1, 2, 3
    • live virus and pseudovirus system: 1, 2, 3, 4
    • live virus and significant neutralization: 1, 2, 3
    • live virus entry and neutralize antibody: 1